$GILD Recent Headlines When it comes to stocks, play

New Post Public Reply Private Reply Replies (0) Message Board

Feb 19, 2014 at 12:39 PM

$GILD Recent Headlines

When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Yum Brands, Take-Two, CME are stocks to watch Tuesday 5:30 a.m. Feb. 4, 2014 - Sue Chang
More positive tests for hep C drug boost AbbVie and Enanta shares 10:52 a.m. Jan. 31, 2014 - blogs.marketwatch.com
Cash ain’t trash 1:55 p.m. Jan. 28, 2014 - The Trading Deck
Beware the dead-cat bounce 1:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 1:06 p.m. Jan. 28, 2014 - Michael Ashbaugh

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog 9:27 a.m. Today - Zacks.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. Feb. 18, 2014 - TheStreet.com
Biotech Remains on Fast Track 11:00 a.m. Feb. 18, 2014 - RealMoney.com
Gilead Sciences: A Great Buy Despite Competition From AbbVie 10:37 a.m. Feb. 18, 2014 - Seeking Alpha
3 Healthcare Stocks That Look Ripe to Rally 6:04 a.m. Feb. 18, 2014 - InvestorPlace.com
3 Stocks Pulling The Drugs Industry Downward 12:03 p.m. Feb. 14, 2014 - TheStreet.com
How To Maximize Potential Return While Protecting Against A Severe Correction 10:50 a.m. Feb. 13, 2014 - Seeking Alpha
Top Pharma and Biotech Stocks to Buy From Key Investor Conference 9:50 a.m. Feb. 13, 2014 - 247WallSt.com
Gilead Sciences: 5 Different Insiders Have Sold Shares This Year 5:00 a.m. Feb. 13, 2014 - Seeking Alpha
Gilead a Given for Hepatitis C Favorite 10:22 a.m. Feb. 12, 2014 - Barrons.com
Stock Market News for February 12, 2014 - Market News 10:06 a.m. Feb. 12, 2014 - Zacks.com
Biotech Stock Roundup: Gilead's Sovaldi Impresses, EU Nod for Biogen's Tecfidera - Analyst Blog 8:27 a.m. Feb. 12, 2014 - Zacks.com
Short Sellers Shy Away From Biotechs 6:04 a.m. Feb. 12, 2014 - 247WallSt.com
Buy GILD Now Before Its Next Breakout 7:16 p.m. Feb. 11, 2014 - InvestorPlace.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. Feb. 11, 2014 - TheStreet.com
Gilead Seeks U.S. Approval - Analyst Blog 4:00 p.m. Feb. 11, 2014 - Zacks.com
Stock Market News for February 11, 2014 - Market News 10:06 a.m. Feb. 11, 2014 - Zacks.com
Gilead +2.8% on positive talk, Sovaldi would make numbers look even better 3:59 p.m. Feb. 10, 2014 - Seeking Alpha
Gilead Going to $90, or $110 2:37 p.m. Feb. 10, 2014 - 247WallSt.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com

CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Today - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
Gilead Sciences to Release Fourth Quarter and Year End 2013 Financial Results on Tuesday, February 4, 2014 5:00 p.m. Jan. 28, 2014 - BusinessWire - BZX
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America 1:15 a.m. Jan. 13, 2014 - BusinessWire - BZX
Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13 5:00 p.m. Jan. 10, 2014 - BusinessWire - BZX
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDX Expands, Enhances Team Amid 56% H1 Growth

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

BrightPlan's AI-Powered Growth: Series C Fuel

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

The Austin Company to Showcase at ISPE Annual Event

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

Verdafero Gains Ground in Sustainable Hospitality

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

ASCEND® Cladding Unveils New Profiles & Texture Variety

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Everpure Surges into the S&P 500: A Milestone Move

Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...

Big Wins at Americas Cardroom's $15M Venom Series

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Stoke Space Raises $1B; XTEND AI Hits NYSE

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Jollibee and DreamWorks Unite for Cultural Celebration

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

AllyGPO Shines as Top Innovator in Health Tech

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...